Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

AlexaFluor-488/TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified Invitrogen Qdot 705

Based on

1 Articles
2011 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

AlexaFluor-488/trans-cyclooctene-modified anti-Ki-67 antibody

AlexaFluor-488/TCO-modified anti-Ki-67 antibody AlexaFluor-488/TCO-modified monoclonal antibody
Type Biomolecule
Formula
Role raw materials
2

tetrazine-modified Invitrogen Qdot 705

Tz-QD
Type Nano Material
Formula
Role graft

Properties

Applications

Area Application Source
diagnostics

0 more entry available to subscribes only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Source
PANC-1 cells

0 more entry available to subscribes only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
Product

AlexaFluor-488/TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified Invitrogen Qdot 705

Method 2

Type: Chemical synthesis
Source:
Starting materials
Product

AlexaFluor-488/TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified Invitrogen Qdot 705

Method 3

Type: Chemical synthesis
Source:
Starting materials
  1. 0RpDaV9wpLfpWGsiEslPb2nPZmaduks6AcKnQHp5mGF4rf3dI8owREmISbWiJXTvfdaNHgd7YY7rsg2XIcr5ZekhrPwTpEUD7VeCFzrAamENn0H4uOwJWxlJF1s4Lww74EJmdjpNweLaCzLTaZ7tBLX4ldbN2oYRoJeegLrOQsl2TfLOT9yXynwy6pTX05at
Product

AlexaFluor-488/TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified Invitrogen Qdot 705

Method 4

Type: Chemical synthesis
Source:
Starting materials
  1. sY4Js8DwxmBBezDr0xCHCoqg4XgP44K6WtjxspzVkKj9dbZJ66IV6HUy3lmdj1wcA8a4PrDfg0mMUFmn7SW3EpIfxBntz3QYhbV3U2AddAv7RqfDJVybDH6WHlaGcuTMT5AZpjEoq2FP3XAd6Nk4CkAfi7R9vjv4ZSB4PwVA7U7gQpseqIhPXXGubp3LQegp
Product

AlexaFluor-488/TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified Invitrogen Qdot 705

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial